As I looked back to 2013, I was hopeful that some companies in the bio lab tools space would show encouraging signs of growth. Illumina Inc. remained the dominant gene sequencer maker and Pacific Biosciences was gaining some traction. Life Technologies’ Ion Torrent business was driving down the cost of gene sequencing. Then I learned in April that Life Technologies was selling itself to Thermo Scientific. It must have been the budget cuts to the NIH’s grant programs that made it too difficult for the company to continue on its own.
Hopefully, 2014 will prove to be a better year for Life’ Ion Torrent business post merger. We predicted that 2014 should be the year of lost cost genomes.
Happy New Year Biotechs.